Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review

<div>(a) 18F FDG PET-CT at relapse showing large soft-tissue mass replacing the T4 vertebral body (white arrow). (b) 18F FDG PET-CT after 2 cycles of KRD-PACE showing near-complete resolution of the extraosseous soft-tissue component involving patient’s known T4 vertebral body lesion (white arrow).</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review 

Figure 1 | Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review 